Best Selling Medication in Spain
- Madrid, Spain – The use of pain relievers in Spain is on the rise, prompting worries among health officials.
- According to the Business Federation of Spanish Pharmacists (FEFE), analgesics topped the list of best-selling medications in the past year, followed by anti-anxiety drugs and cholesterol treatments.
- A November 2024 report by Infonis and IQVIA consultants revealed that nine of the 30 best-selling medications in Spain are analgesics, with five anxiolytics and three cholesterol-lowering drugs...
Spain’s Appetite for Analgesics Grows, Raising Concerns
Madrid, Spain – The use of pain relievers in Spain is on the rise, prompting worries among health officials. Data from the Ministry of Health indicates an increase of more than 11% in analgesic consumption in 2021 compared to the previous year.
According to the Business Federation of Spanish Pharmacists (FEFE), analgesics topped the list of best-selling medications in the past year, followed by anti-anxiety drugs and cholesterol treatments.
A November 2024 report by Infonis and IQVIA consultants revealed that nine of the 30 best-selling medications in Spain are analgesics, with five anxiolytics and three cholesterol-lowering drugs also making the list.
Nolotil Remains Spain’s Top-Selling Drug
The analgesic Nolotil continues to be the most frequently purchased medication in Spain. The FEFE list shows that 28.6 million units of Nolotil were sold in Spanish pharmacies as of november 2024.
Adiro 100, an antiplatelet medication used to prevent blood clot formation, ranked second with 19.1 million units sold. Following Adiro 100, three other analgesics are among the top sellers:
- Kern Pharma Paracetamol: 18.8 million units
- Cinfa Paracetamol: 16.7 million units
- Enantyum: 16.3 million units
Controversy Surrounds Top Seller Nolotil
Despite its popularity, Nolotil is not without controversy. The drug’s active ingredient, metamizole, is a pyrazolone derivative with analgesic and antipyretic properties. Like all medications, metamizole carries the risk of side effects.
Agranulocytosis, a severe and potentially perilous drop in white blood cell count, is among the most concerning side effects associated with metamizole.
Reports linking Nolotil to agranulocytosis surfaced in 2023. Despite these reports, the Spanish Agency for Medicines and Health Products (AEMPS) continued to recommend its use, issuing an advisory note in December 2023 outlining precautions to minimize the risk of agranulocytosis.
The Association of Drug Affected (ADAF) filed a lawsuit with the National Court, citing severe adverse reactions linked to metamizole. concerns about the drug date back several years; in 2018, the Ministry of Health issued a warning regarding its misuse.
Nolotil is a prescription medication and should only be taken under medical supervision.
Spain’s Appetite for Analgesics: A Growing Concern – Your FAQs Answered
H2: Why is the use of pain relievers in Spain a growing concern?
The use of pain relievers, or analgesics, in Spain is on the rise. Health officials are worried due to an increase of over 11% in analgesic consumption in 2021 compared to the previous year, as indicated by data from the Ministry of Health. This spike prompts careful examination of usage and potential health implications.
H2: Which types of medications are most commonly used in Spain?
According to the Business Federation of Spanish Pharmacists (FEFE), analgesics were the top-selling medications in spain. This was followed by anti-anxiety drugs and cholesterol treatments.
H2: What is the most frequently purchased medication in Spain?
Nolotil, an analgesic, continues to be the most frequently purchased medication in Spain. In November 2024, 28.6 million units were sold in Spanish pharmacies, according to the FEFE list.This makes it the top-selling drug by a meaningful margin.
H2: What other pain relievers are popular in Spain?
Following Nolotil and Adiro 100 (an antiplatelet medication), are several other popular analgesics, specifically:
Kern Pharma Paracetamol: 18.8 million units
Cinfa Paracetamol: 16.7 million units
* Enantyum: 16.3 million units
H2: Are there any concerns surrounding the top-selling drug, nolotil?
Yes, despite its widespread use, Nolotil is associated with controversy. Its active ingredient, metamizole, is linked to the risk of side effects, with agranulocytosis being the most concerning.
H2: What is Agranulocytosis?
Agranulocytosis is a severe and potentially life-threatening condition that involves a drastic reduction in white blood cell count. This weakens the body’s ability to fight infections, making individuals more susceptible to illness.
H2: What is the role of Metamizole in Nolotil?
Metamizole is the active ingredient in Nolotil. It is a pyrazolone derivative that provides analgesic (pain-relieving) and antipyretic (fever-reducing) effects.
H2: What is the current suggestion for Nolotil use?
Nolotil is a prescription medication, and its use should only be under medical supervision. despite reports of adverse reactions,the Spanish Agency for Medicines and Health Products (AEMPS) continues to recommend its use,issuing advisory notes outlining precautions to minimize risk.
H2: Summarizing Key Facts About Nolotil and Other Popular Medications:
| Medication | Active ingredient(s) | Primary Use | Units Sold (Approx. Nov 2024) | Known Concerns/Side Effects |
| :————————– | :——————– | :———————————– | :—————————— | :————————————– |
| Nolotil | Metamizole | Pain Relief | 28.6 million | agranulocytosis |
| Adiro 100 | Aspirin | Prevent Blood Clots | 19.1 million | Bleeding,stomach ulcers |
| Kern Pharma Paracetamol | Paracetamol | Pain Relief,Fever Reduction | 18.8 million | Liver damage (overdose) |
| Cinfa Paracetamol | Paracetamol | Pain Relief, Fever reduction | 16.7 million | Liver damage (overdose) |
| Enantyum | Dexketoprofen | Pain Relief | 16.3 million | Gastrointestinal issues, kidney issues |
H2: What actions have been taken regarding concerns about Nolotil?
The Association of Drug affected (ADAF) filed a lawsuit with the National Court, citing severe adverse reactions linked to metamizole. Concerns about the drug date back several years; in 2018, the Ministry of Health issued a warning regarding its misuse. Moreover, there have been investigations into the potential link with agranulocytosis.
H2: Where can I get more information about using pain relievers?
Always consult with a healthcare professional for advice related to taking any medications.They can provide guidance on the appropriate use, potential risks, and side effects of pain relievers based on your individual health needs. The Spanish Agency for Medicines and Health Products (AEMPS) is an official source for medication information.